HIGHLIGHTS OF 10 OVERDOSAGE Mean Points Seen (SD) in ...
Horner syndrome, myasthenia gravis, external ophthalmoplegia, orbital infection and orbital masses. Consideration should be given to these conditions in the presence of ptosis with decreased levator muscle function and/or other neurologic signs [see Warnings and Precautions (5.1)]. • Alpha-adrenergic agonists as a class may impact blood pressure.
Tags:
Information
Domain:
Source:
Link to this page:
Related documents
METHIMAZOLE - Today's Veterinary Practice
todaysveterinarypractice.comexfoliative dermatitis, myasthenia gravis,8 and a bleeding disorder secondary to vitamin K antagonism. Drug Interactions • Anticoagulants may be potentiated by the antivitamin K activity of methimazole. • Decreased clinical efficacy of phenobarbital if the drugs are used concurrently. • A reduction in dose of certain drugs (alpha adrenergic
Medrol Dosepak Uses, Side Effects & Warnings - Drugs
www.lb7.uscourts.gova muscle disorder such as myasthenia gravis; or multiple sclerosis. Also tell your doctor if you have diabetes. Steroid medicines may increase the glucose (sugar) levels in ... Other drugs may interact with methylprednisolone, including prescription and over-the-counter medicines, vitamins, and herbal products. ...
Rapid Sequence Intubation (RSI)
www.hahv.orgo Dose: 1.5 mg/kg IV (2 mg/kg IV if myasthenia gravis), 4 mg/kg IM (in extremis) o Onset: 45-60 seconds o Duration: 6-10 minutes o Use: ideal if need to extubate rapidly following an elective procedure or to assess neurology in an intubated patient o Drawbacks: numerous contra-indications (hyperkalemia, malignant hyperthermia,
UnitedHealthcare Medication List Maintenance ... - myuhc
www.myuhc.commyasthenia gravis mestinon mytelase prostigmin pyridostigmine bromide neuropathic pain gabapentin gralise* horizant* lyrica osteoporosis actonel alendronate sodium atelvia* binosto* boniva etidronate disodium evista+ ibandronate sodium risedronate overactive bladder darifenacin er* detrol* detrol la* ditropan xl enablex* gelnique* drug name ...
FEP® Blue Focus Formulary (907)
www.caremark.comDrugs first marketed between 1938 and 1962 were approved as safe but required no showing of effectiveness for FDA approval. Since 1962, all new drugs are required to be both safe and effective before they can be marketed. The legislation that resulted in this change also applies retroactively to all drugs approved as safe from 1938-1962.